ATE555112T1 - Imidazoä4,5-büpyridin-2-onderivate und analoga davon als verbindungen für die krebstherapie - Google Patents

Imidazoä4,5-büpyridin-2-onderivate und analoga davon als verbindungen für die krebstherapie

Info

Publication number: ATE555112T1
Authority: AT; Austria
Prior art keywords: compounds; imidazoä4; bupyridine; analogs; derivatives
Prior art date: 2006-04-26

Application number

AT07732571T

Other languages

English (en)

Inventor

Dan Niculescu-Duvaz

Caroline Springer

Richard Marais

Harmen Dijkstra

Delphine Menard

Ion Niculescu-Duvaz

Lawrence Davies

Arnaud Nourry

Original Assignee

Cancer Rec Tech Ltd

Inst Of Cancer Res The Royal Cancer Hospital

Astex Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-26

Filing date

2007-04-26

Publication date

2012-05-15

2007-04-26 Application filed by Cancer Rec Tech Ltd, Inst Of Cancer Res The Royal Cancer Hospital, Astex Therapeutics Ltd filed Critical Cancer Rec Tech Ltd

2007-04-26 Priority claimed from PCT/GB2007/001534 external-priority patent/WO2007125330A1/en

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE555112T1 publication Critical patent/ATE555112T1/de

Links

150000001875 compounds Chemical class 0.000 title abstract 2
238000011275 oncology therapy Methods 0.000 title 1
WURJYZYJCUDTQO-UHFFFAOYSA-N 3-fluoro-5-morpholin-4-yl-n-[3-[(2-oxo-1,3-dihydroimidazo[4,5-b]pyridin-7-yl)oxy]phenyl]benzamide Chemical compound C=1C(C(=O)NC=2C=C(OC=3C=4NC(=O)NC=4N=CC=3)C=CC=2)=CC(F)=CC=1N1CCOCC1 WURJYZYJCUDTQO-UHFFFAOYSA-N 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
JXXWJMUPNZDILL-UHFFFAOYSA-N imidazo[4,5-b]pyridin-2-one Chemical class C1=CC=NC2=NC(=O)N=C21 JXXWJMUPNZDILL-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT07732571T 2006-04-26 2007-04-26 Imidazoä4,5-büpyridin-2-onderivate und analoga davon als verbindungen für die krebstherapie ATE555112T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US74563306P	2006-04-26	2006-04-26
GBGB0608268.9A GB0608268D0 (en)	2006-04-26	2006-04-26	Therapeutic compounds
PCT/GB2007/001534 WO2007125330A1 (en)	2006-04-26	2007-04-26	Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds

Publications (1)

Publication Number	Publication Date
ATE555112T1 true ATE555112T1 (de)	2012-05-15

Family

ID=36589863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07732571T ATE555112T1 (de)	2006-04-26	2007-04-26	Imidazoä4,5-büpyridin-2-onderivate und analoga davon als verbindungen für die krebstherapie

Country Status (6)

Country	Link
CN (1)	CN101479264A (de)
AT (1)	ATE555112T1 (de)
BR (1)	BRPI0710808A2 (de)
ES (1)	ES2385103T3 (de)
GB (1)	GB0608268D0 (de)
NZ (1)	NZ572246A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201111385A (en) *	2009-08-27	2011-04-01	Biocryst Pharm Inc	Heterocyclic compounds as janus kinase inhibitors
CN109641892B (zh) *	2016-08-16	2021-07-02	默克专利有限公司	用作可逆btk抑制剂的2-氧代-咪唑并吡啶及其用途
AU2020367204A1 (en) *	2019-10-15	2022-04-14	Aucentra Therapeutics Pty Ltd	Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-N-(pyridin-3-yl) pyrimidin-2- amine for treating proliferative diseases and conditions

2006
- 2006-04-26 GB GBGB0608268.9A patent/GB0608268D0/en not_active Ceased
2007
- 2007-04-26 BR BRPI0710808-7A patent/BRPI0710808A2/pt not_active IP Right Cessation
- 2007-04-26 CN CNA2007800238840A patent/CN101479264A/zh active Pending
- 2007-04-26 ES ES07732571T patent/ES2385103T3/es active Active
- 2007-04-26 NZ NZ572246A patent/NZ572246A/en not_active IP Right Cessation
- 2007-04-26 AT AT07732571T patent/ATE555112T1/de active

Also Published As

Publication number	Publication date
NZ572246A (en)	2011-12-22
BRPI0710808A2 (pt)	2012-01-31
ES2385103T3 (es)	2012-07-18
CN101479264A (zh)	2009-07-08
GB0608268D0 (en)	2006-06-07

Similar Documents

Publication	Publication Date	Title
UA99459C2 (en)	2012-08-27	9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
TW200621762A (en)	2006-07-01	Novel compounds
NO20091893L (no)	2009-07-09	Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
SG170101A1 (en)	2011-04-29	2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
NO20092723L (no)	2009-09-07	Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
BRPI0714320A2 (pt)	2014-06-24	Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica
EA200870360A1 (ru)	2009-02-27	Бензимидазолы, обладающие активностью в отношении рецепторов м1, и их применение в медицине
EA201300620A1 (ru)	2013-12-30	ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНА И ИМИДАЗО[4,5-b]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ JAK
BR112014000240A2 (pt)	2017-06-13	derivados de benzilamina como inibidores de calicreína plasmática
NO20084129L (no)	2008-10-29	Pyridin(3,4-B)Pyrazinoner
NO20092227L (no)	2009-08-17	Salter og krystallformer av 2-metyl-2-[4-(3-metyl-2-okso-8-konolin-3-yl-2,3-dihydro-imidazo[4,5-C]kinolin-1-yl)-fenyl]-propionitril
NO20080408L (no)	2008-03-25	Azaindazolforbindelser og anvendelse derav
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
MX2008013836A (es)	2008-11-10	Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
NO20082496L (no)	2008-07-24	Pyrazinderivater
TW200519111A (en)	2005-06-16	N3-substituted imidazopyridine C-KIT inhibitors
MXPA04005886A (es)	2004-09-13	Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
NZ596739A (en)	2014-01-31	Methods of treating proliferative diseases
NO20070837L (no)	2007-04-16	Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
WO2008049855A3 (en)	2008-08-14	7-azaindole derivatives as c-met kinase inhibitors
DE602007002915D1 (de)	2009-12-03	2-benzoyl-imidazopyridin-derivate, herstellungsverfahren und ihre verwendung für therapeutika
ATE452896T1 (de)	2010-01-15	C3-cyanoepothilonderivate
ES2340502T3 (es)	2010-06-04	Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad.
MX2008011576A (es)	2008-09-22	Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
NO20080937L (no)	2008-04-30	Substituerte-3-sulfonylindazolderivater som 5-hydroksytryptamin-6-ligander